Sponsor study identifier
observational
90
1 country
1
Study Start
July 2011
Actual (reported)Primary Completion
July 2017
Actual (reported)Study Completion
July 2017
Actual (reported)Multi-site Communication Deficits Underlying Cognitive Dysfunction in the Prodromal Phase and First Episode of Schizophrenia
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2017
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 15, 2011
Actual (reported)March 17, 2011
Actual (reported)July 2011
Actual (reported)July 2017
Actual (reported)July 2017
Actual (reported)Brain function
baseline and one-year follow-up
Identification and clinical characterization of subjects with prodromal symptoms will be done in the early diagnosis outpatient center of the University Department of Psychiatry in Hamburg, Germany. Subjects At Risk Mental State (ARMS) for psychosis will be identified if they meet the criteria of the Structured Interview for Prodromal Syndromes (SIPS) (McGlashan et al 2001).
Patients with a first episode of schizophrenia will be recruited from inpatients at the Clinic for Psychiatry and Psychotherapy at the University Hospital (UKE) in Hamburg, Germany. All patients have to meet criteria for DSM-IV and ICD-10 diagnosis for schizophrenia.
Healthy control subjects will be recruited from the hospital staff and students at the University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany. They have to be free from any neurological or psychiatric disorder, according to DSM-IV and ICD-10 criteria.
Three groups of subjects will be included: patients with a first episode of schizophrenia, subjects at increased risk for schizophrenia, and healthy control subjects.
Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf (UKE)
Hamburg, 20246, Germany
Christoph Mulert, Prof. Dr.
University Medical Center Hamburg-Eppendorf, Department of Psychiatry
90 participants (actual enrollment reported by the registry).
First Submitted
March 15, 2011
First Posted
March 17, 2011
Study Start
July 2011
Actual (reported)Psychosis-Associated Neuroinflammation in Schizophrenia
Contact the study team to confirm eligibility.
Primary Completion
July 2017
Actual (reported)Study Completion
July 2017
Actual (reported)Last Updated
February 10, 2021
Record last verified: 2021-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: